BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11313943)

  • 21. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
    Yam JW; Chan KW; Hsiao WL
    Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutaredoxin is a direct target of oncogenic jun.
    Goller ME; Iacovoni JS; Vogt PK; Kruse U
    Oncogene; 1998 Jun; 16(22):2945-8. PubMed ID: 9671415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quail long-term cell culture transformed by a chimeric jun oncogene.
    Hartl M; Vogt PK; Bister K
    Virology; 1995 Feb; 207(1):321-6. PubMed ID: 7871748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. v-Jun downregulates the alpha 2 (I) collagen target gene indirectly through Sp1/3.
    Chamboredon S; Castellazzi M
    Oncogene; 2005 Apr; 24(15):2547-57. PubMed ID: 15735704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TNF-alpha and its receptors in the production of Src-suppressed C kinase substrate by rat primary type-2 astrocytes.
    Yan M; Xia C; Cheng C; Shao X; Niu S; Liu H; Shen A
    Brain Res; 2007 Dec; 1184():28-37. PubMed ID: 17980351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jun, the oncoprotein.
    Vogt PK
    Oncogene; 2001 Apr; 20(19):2365-77. PubMed ID: 11402333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype.
    Gapuzan ME; Yufit PV; Gilmore TD
    Oncogene; 2002 Apr; 21(16):2484-92. PubMed ID: 11971183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).
    Miura Y; Kainuma M; Jiang H; Velasco H; Vogt PK; Hakomori S
    Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16204-9. PubMed ID: 15534203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line.
    Liu H; Huang X; Wang H; Shen A; Cheng C
    Brain Res; 2009 Apr; 1265():1-12. PubMed ID: 19368818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation.
    Kho CJ; Wang Y; Zarbl H
    Cell Growth Differ; 1996 Sep; 7(9):1157-66. PubMed ID: 8877097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.
    Fu Sl; Bottoli I; Goller M; Vogt PK
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5716-21. PubMed ID: 10318950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation.
    Nishizawa M; Fu SL; Kataoka K; Vogt PK
    Oncogene; 2003 Sep; 22(39):7931-41. PubMed ID: 12970741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of serum concentration on the expression of carcinogen-induced transformation in the C3H/10T1/2 CL8 cell line.
    Bertram JS
    Cancer Res; 1977 Feb; 37(2):514-23. PubMed ID: 401680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological alteration of X-ray induced partially transformed human cells by transfection with a small c-myc DNA sequence.
    Kano Y; Nohno T; Takahashi R; Hiragami F; Kawamura K; Strebhardt K; Namba M; Sugiyama T; Little JB
    Biochem Biophys Res Commun; 2000 Jun; 272(3):887-94. PubMed ID: 10860847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response.
    Nelson PJ; Gelman IH
    Mol Cell Biochem; 1997 Oct; 175(1-2):233-41. PubMed ID: 9350056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered growth and spontaneous transformation of cells cultured from v-jun transgenic mice recapitulate wound-induced multistage tumorigenesis.
    Schuh AC; Theodorescu D; Shalaby F; Breitman ML
    Cell Growth Differ; 1993 Mar; 4(3):177-84. PubMed ID: 8466856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-suppressive activity of N03 gene product in v-src-transformed rat 3Y1 fibroblasts.
    Ozaki T; Sakiyama S
    Cancer Res; 1994 Feb; 54(3):646-8. PubMed ID: 8306325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutaraldehyde-fixed transformed and non-transformed cells induce contact-dependent inhibition of growth in non-transformed C3H/10T1/2 mouse fibroblasts, but not in 3-methylcholanthrene-transformed cells.
    Oesch F; Janik-Schmitt B; Ludewig G; Glatt H; Wieser RJ
    Eur J Cell Biol; 1987 Jun; 43(3):403-7. PubMed ID: 3113956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.